Article Information
History
- August 7, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Zahra Rikhtegaran Tehrani1,2,
- Saman Saadat1,2,
- Ebtehal Saleh3,
- Xin Ouyang1,
- Niel Constantine3,
- Anthony L. DeVico2,
- Anthony D Harris4,
- George K. Lewis2,
- Shyam Kottilil1 and
- Mohammad M. Sajadi1,2,5,*
- 1Division of Clinical Care and Research, Institute of Human Virology, University of Maryland, Baltimore, Maryland 21201, USA
- 2Division of Vaccine Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
- 3Division of Epidemiology & Prevention, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
- 4Department of Epidemiology and Public Health, University of Maryland School of Medicine Baltimore, Maryland 21201, USA, Department of Medicine, Baltimore VA Medical Center, Baltimore, Maryland 21201, USA
- 5Department of Medicine, Baltimore VA Medical Center, Baltimore, Maryland 21201, USA
- ↵*
Correspondence
: msajadi{at}ihv.umaryland.edu.
Posted August 07, 2020.
Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic Assays
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos